Best Parp Inhibitors Podcasts (2024)

1
Mo Li on PARP inhibitors 15:59

9d ago15:59

15:59

Dr. Mo Li from Peking University Third Hospital discusses his publication "PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response". Read the full article: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00164-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom Continue this co…

1
Mansoor Raza Mirza, MD / Ana Oaknin, MD, PhD - Navigating Recent Advances in Endometrial Carcinoma Treatment: Expert Guidance to Unleash the Power of Immunotherapy and Other Emerging Therapeutic Regimens ... 49:39

10d ago49:39

49:39

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE c…

1
Andrea Necchi, MD - Candid Conversations on Modern Urothelial Cancer Management: Personalizing Patient Care Using the Latest Evidence and Innovative Therapeutic Strategies 1:32:29

15d ago1:32:29

1:32:29

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJT8…

1
Petros Grivas, MD, PhD - Maximizing the Role of ADCs in Urothelial Carcinoma: Practical Tips for Patient Selection, Safety Management, and Collaborative Care 1:31:33

15d ago1:31:33

1:31:33

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MBD8…

1
Karim Fizazi, MD, PhD - Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer: Experts Put the Pressure on Key Evidence and Real-World Strategies to Optimize Patient Care 1:32:31

19d ago1:32:31

1:32:31

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YWU8…

1
Carla M. Nester, MD, MSA, FASN - Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evolving Landscape of Glomerular Kidney Disease Management 28:59

24d ago28:59

28:59

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XWR865. CME credit will…

1
Sanja Jelic & Daniel Gottlieb on the impact of CPAP on biomarkers 18:11

2M ago18:11

18:11

Sanja Jelic & Daniel Gottlieb join eBioMedicine to discuss the use of continuous positive airway pressure in obstructive sleep apnoea and its impact on cardiovascular and inflammatory markers. Read the full article: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00050-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom Continue…

1
Sia Daneshmand, MD / Matthew D. Galsky, MD - Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Strategies for Integrating the Latest Evidence and Treatment Advances 1:02:43

2M ago1:02:43

1:02:43

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/XSE8…

1
Neal D. Shore, MD, FACS - Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Implementing Modern Therapeutic Advances Across the Disease Continuum 1:23:25

2M ago1:23:25

1:23:25

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DME8…

1
Alicia K. Morgans, MD, MPH, Neal D. Shore, MD, FACS - Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy ... 59:06

3M ago59:06

59:06

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Kathleen N. Moore, MD, MS - Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies 1:17:35

3M ago1:17:35

1:17:35

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CVY8…

1
Bradley J. Monk, MD, FACS, FACOG - Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Implementation Strategies, and Patient Care 59:56

3M ago59:56

59:56

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VRN8…

1
Prof. Laurence Albiges, MD, PhD - Exploring New Routes in Immuno-Oncology: Understanding the Role of Subcutaneous Immune Checkpoint Inhibitors and Preparing for Innovative Delivery Approaches in the Clinic ... 24:25

4M ago24:25

24:25

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Matthew D. Galsky, MD - Making an Impact in Bladder Cancer Care: Integrating the Latest Evidence and Modern Therapeutic Advances Across the Disease Continuum 1:30:25

4M ago1:30:25

1:30:25

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JSQ865. C…

1
Robert Dreicer, MD, MS, MACP, FASCO - Doing Better Under Pressure in Prostate Cancer: Key Evidence and Real-World Care Strategies 1:24:58

5M ago1:24:58

1:24:58

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YRR865. C…

1
Sumanta Kumar Pal, MD, FASCO - Advancing Personalized Care in RCC: Navigating Rapid Therapeutic Expansion and Sequencing Strategies 1:29:00

5M ago1:29:00

1:29:00

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/XZU8…

1
Neal D. Shore, MD, FACS - Pioneering Precision Medicine in Bladder Cancer: Multidisciplinary Perspectives on Personalizing Patient Care 1:01:12

6M ago1:01:12

1:01:12

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XJV865. CME/MO…

1
S5 Ep2: BRCA Gene Journey 45:28

6M ago45:28

45:28

I discuss the reality of a BRCA gene mutation diagnosis with Kritsa Costello of BRCA Ireland. Krista shares her incredible, inspiring and courageous story.By Dr. Doireann’s Podcast

1
S5 Ep1: Treatment of HPV; Papilocare with Dr. Damian Dexeus. 32:55

7M ago32:55

32:55

I discuss Papilocare, a new over the counter, vaginal gel treatment for HPV with Dr. Damian Dexeus. Dr. Damian Dexeus, Medical Director of the Women's Gynaecological Clinic in Barcelona is a specialist in Gynaecology and Obstetrics. His interests include the study of premature babies, Human papillomavirus (HPV), gynaecological cancer and breast can…

1
Neal D. Shore, MD, FACS - Under Pressure to Improve Prostate Cancer Care: Unlocking the Power of Advanced Therapeutics to Enhance Outcomes Across the Disease Continuum 1:04:42

7M ago1:04:42

1:04:42

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAR865. CME/MO…

1
S4 Ep6: ISGO: Public and Patient Involvement 25:30

7M ago25:30

25:30

"Nothing About Me Without Me": Sharon O’Toole is a senior research fellow in Trinity College Dublin working in the area of gynaecological cancer. She sits on the board of ISGO and co-founded a public and patient involvement group (ISGOPPI) within the society. Public and patient involvement known as PPI is where patients and members of the public ge…

1
Sumanta Kumar Pal, MD, FASCO - Leveling Up Our RCC Care Strategy: Real-World Translation of Key Evidence Across Treatment Settings 58:19

7M ago58:19

58:19

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/DJA865. CME/MO…

1
Bradley J. Monk, MD, FACS, FACOG - The ABCs of ADCs for Gynecologic Cancer: Expert Insights on Effective Implementation and Practical Tips for Use in Patients With Cervical, Ovarian, or Endometrial Cancer ... 40:36

7M ago40:36

40:36

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BVX865. C…

1
S4 Ep5: ISGO: Gestational Trophoblastic Disease 44:02

8M ago44:02

44:02

Dr. John Coulter, Consultant Obstetrician and Gynaecological Oncologist and Clinical Lead of The National Gestational Trophoblastic Disease Centre at Cork University Maternity Hospital explains Gestational Trophoblastic Disease, also known as "Molar Pregnancy". Patient advocate, Rachel shares her lived experience of GTD.…

1
S4 Ep4: ISGO: Psychosexual Impact of Fertility Treatment and Cancer 35:06

8M ago35:06

35:06

In this episode I speak with Tamsin who discusses the impact of fertility and cancer treatment had and still has on her relationship. I also speak with Dr. Yvonne O'Meara, Systemic Psychotherapist and Psychosocial Oncologist, who gives expert insight in to the psychosexual impact of cancer on relationships. For more information on gynaecological ca…

1
Updates in the Treatment of Patients with EGFR Exon 20 Insertion Mutation NSCLC 10:17

9M ago10:17

10:17

This podcast provides an overview of current and emerging data available in the treatment of EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer, including updates from ESMO 2023. Key takeaways:- Review treatment options for EGFR Exon 20 Insertion Mutations in NSCLC - Review updated clinical data from ELCC and ESMO 2023 - Gain an understandi…

1
Hiddo J.L. Heerspink, PhD, PharmD / Prof. Dr. med Christoph Wanner - Chronic Kidney Disease in Patients With Type 2 Diabetes: The Impetus for Early Recognition and Strategies for Coordinating Optimal ... 26:41

8M ago26:41

26:41

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZSZ865. CME credit will…

1
Eddy Pasquier & Marion LeGrand on druggable cancer vulnerabilities 13:16

9M ago13:16

13:16

Drs. Pasquier and LeGrand join eBioMedicine to discuss their stepwise approach to unveil druggable cancer vulnerabilities and to fast-track the identification of synergistic combinations against glioblastoma. Read the full article: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00317-1/fulltext?dgcid=buzzsprout_icw_podcast_generi…

1
S4 Ep3: Redefining Palliative Care. 34:37

9M ago34:37

34:37

In episode 3 of The ISGO podcast we speak with Dr. Karie Dennehy and Dr. Miriam Colleran, Consultants in Palliative Medicine about the care they give to patients and their family. We then speak with Anne, a patient living with Ovarian Cancer; Anne describes what Palliative Medicine means to her. References from our discussion with Dr. Miriam Coller…

1
S4 Ep2: ISGO: Living with Ovarian Cancer and PARP Inhibitor Medications. 28:48

10M ago28:48

28:48

In episode 2 of the ISGO podcast, we speak with Dr. Dearbhaile Collins, Consultant Medical Oncologist, who explains medications known as PARP inhibitors, how they work and who they're suitable for. We then speak with Jenny, a patient living with Ovarian Cancer, and who takes a PARP inhibitor medication.…

1
Alan Dangour on climate change and health 15:38

10M ago15:38

15:38

Alan Dangour joins eBioMedicine to discuss climate change and health, our recently published Series, and projects they are working on at The Wellcome Trust. Read the full Series: https://www.thelancet.com/series/climate-change-and-health?dgcid=buzzsprout_icw_podcast_generic_ebiom Continue this conversation on social! Follow us today at... https://t…

1
S4 Ep1: ISGO: Lived Experience of Genetic Testing. 32:49

10M ago32:49

32:49

Genetic screening is recommended when a specific cancer appears to run in a family. BRCA and Lynch syndrome are two conditions, that when inherited, predispose someone to developing a number of different cancers. BRCA 1 and BRCA 2 are tumour suppressor genes. When they function normally they stop cells in the breast, ovary and other tissues from di…

1
John Cryan on the microbiome-gut-brain axis and binge drinking 21:40

1y ago21:40

21:40

John Cryan joins eBioMedicine to discuss how the microbiome-gut-brain axis regulates social cognition and craving in young binge drinkers. Read the full article: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00007-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom Continue this conversation on social! Follow us today at... ht…

1
Sumanta Kumar Pal, MD, FASCO - Fine-Tuning the Wave of Innovation in RCC: Personalized Management Across the Disease Spectrum 1:23:33

1y ago1:23:33

1:23:33

Go online to PeerView.com/DGX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Innovation in renal cell carcinoma (RCC) has brought new opportunities to improve patient outcomes through personalized medicine. With multiple FDA approvals and promising agents being explored in a variety of setting…

1
David M. O'Malley, MD - Endometrial Cancer Care in the Age of Immunotherapy: Translating Clinical Evidence Into Meaningful Improvements in Patient Outcomes Across the Disease Continuum 1:22:46

1y ago1:22:46

1:22:46

Go online to PeerView.com/UDV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While recurrent or advanced endometrial cancer (EC) has traditionally been associated with a poor prognosis, the use of immune checkpoint inhibition (ICI) in both monotherapy and combination approaches has led to impr…

1
Benjamin M. Brucker, MD - Can We Improve Management of Overactive Bladder in Long-Term Care? Examining the Role of Beta-3 Adrenergic Agonists 57:27

1y ago57:27

57:27

Go online to PeerView.com/QGG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Overactive bladder is frequently underdiagnosed and undertreated, but fortunately there's a newer treatment option with the beta-3 adrenoreceptor agonists. This class demonstrates efficacy without anticholinergic adve…

1
Kimberly Halla, MSN, FNP-C - Expert Nursing Insights on Personalized Care for Gynecologic Cancers: Educating and Supporting Patients on the Latest Therapeutic Approaches 1:34:34

1y ago1:34:34

1:34:34

Go online to PeerView.com/VRD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the therapeutic landscape for gynecologic cancers (ovarian, endometrial, and cervical) rapidly evolves, how can oncology nurses effectively support patients and integrate the growing clinical evidence for approved …

1
Brenda Martone, MSN, ANP-BC, AOCNP - Meeting Patient Needs Through Optimal Nursing Strategies in Personalized Bladder Cancer Care 1:06:24

1y ago1:06:24

1:06:24

Go online to PeerView.com/VTJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The therapeutic landscape for bladder cancer has rapidly evolved. The largely chemotherapy-based approaches of the past are giving way to the use of immune checkpoint inhibitors, targeted agents, and antibody–drug con…

1
Linda R. Duska, MD, MPH / Debra L. Richardson, MD, FACS, FACOG - Upgrading the Treatment Algorithm for Advanced Ovarian Cancer: Expert Tips, Tools, and Patient Care Strategies for Making the Most of PARP ... 52:30

1y ago52:30

52:30

Go online to PeerView.com/UNZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this discussion-based activity, two experts on ovarian cancer discuss the role of PARP inhibitors in treating advanced ovarian cancer. Upon completion of this activity, participants should be better able to: Adapt …

1
Alvaro Berbís & David McClintock on computational pathology in 2030 12:54

1y ago12:54

12:54

Drs Berbís and McClintock join eBioMedicine to discuss the survey they conducted with experts, forecasting the role of AI in pathology within the next decade. Read the full article: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00609-0/fulltext?dgcid=buzzsprout_icw_podcast_ebiom_lancet Continue this conversation on social! Follo…

1
Matthew D. Galsky, MD, Neal D. Shore, MD, FACS - The New Immuno-Oncology Era in Early-Stage Bladder Cancer: Readying the Modern Urology Practice 1:02:32

1+ y ago1:02:32

1:02:32

Go online to PeerView.com/FPT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you fully prepared as we move further into the immune checkpoint inhibitor (ICI) era in early-stage bladder cancer? Already well established in metastatic urothelial carcinoma, the role of ICIs has now been valida…

1
Saira Z. Sheikh, MD, FAAAAI, FACAAI, FACR, Brad Rovin, MD, FASN, FACP - Improving the Patient Experience in SLE and LN: The Intersection of Early Diagnosis, Individualized Treatment, and Culturally Competent ... 52:51

1+ y ago52:51

52:51

Go online to PeerView.com/JPU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Observed differences in healthcare disparities for patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) have led to the recognition of racial and ethnic minorities as an independent predictor of w…

1
Matthew I. Milowsky, MD, FASCO - Fresh Perspectives on Moving Toward Personalized Care for Bladder Cancer: Tips, Tools, and Strategies for Leveraging the Latest Advancements Across the Disease Spectrum ... 1:28:44

1+ y ago1:28:44

1:28:44

Go online to PeerView.com/KPE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Management of advanced/metastatic urothelial cancer has undergone a significant transformation with the addition of PD-1– and PD-L1–targeting immune checkpoint inhibitors (ICIs) to the treatment armamentarium. These a…

1
Matthew R. Smith, MD, PhD - Expanding Use of Hormonal Therapeutic Strategies in Prostate Cancer: Clinical Evidence and Practical Considerations for Individualized, Patient-Centered Care 1:23:44

1+ y ago1:23:44

1:23:44

Go online to PeerView.com/PNF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. “Treatment intensification”—or the use of combination treatment strategies—has now become the standard of care for patients with metastatic hormone-sensitive prostate cancer. Shown to extend overall survival beyond si…

1
Sumanta Kumar Pal, MD, FASCO - Breaking New Ground in RCC Management: Expert Guidance on Leveraging Therapeutic Strategies 1:28:18

1+ y ago1:28:18

1:28:18

Go online to PeerView.com/FFQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the number of approved treatment strategies in renal cell carcinoma (RCC) grows, there are new opportunities to provide personalized medicine to patients in a variety of settings. Multi-targeted TKIs, immune checkp…

1
Marwan Sabbagh, MD, FAAN - Translating the Latest Research Advances Into Routine Care for Alzheimer’s Disease: Preparing Dementia Specialists With the Latest Strategies to Support Early Diagnosis and Comprehensive ... 1:03:06

1+ y ago1:03:06

1:03:06

Go online to PeerView.com/GAZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in neurology discusses strategies for optimizing the biomarker-based diagnosis of Alzheimer’s disease early in the disease course and the selection of appropriate patients who might benefit…

1
Peter Robinson and Justin Reese on Long COVID subtypes 21:54

1+ y ago21:54

21:54

Drs Robinson and Reese join eBioMedicine to discuss their findings on semantic phenotypic clustering long COVID subtypes observed in N3C and RECOVER programmes. Read the full article: Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes Continue this conversation on social! Follow us today at... https://twitter.com/th…

1
S3 Ep5: How to Reduce Risk of Pelvic Floor Injury and Instrumental Delivery During Childbirth; What You Need to Know 54:24

1+ y ago54:24

54:24

Shalini Wiseman is back with her top tips for childbirth and how to reduce risk of pelvic floor injury, episiotomy and instrumental delivery. A must listen for all pregnant women, their partners and anyone on their TTC journeyBy Dr. Doireann’s Podcast

1
Gerald Appel, MD, PhD - Targeted Complements: Exploring New Horizons Designed to Address Gaps in Treating Complement-Associated Kidney Diseases 28:36

1+ y ago28:36

28:36

Go online to PeerView.com/FSW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Explore new horizons in complement-targeted treatments with two leading experts who share fresh insights into the underlying pathophysiology of complement-associated kidney diseases and provide evidence-based guidance…

1
Ke-Wu Zeng on molecular glues for cancer therapy 14:04

1+ y ago14:04

14:04

Drs Zeng join eBioMedicine to discuss their study of a novel molecular glue, called bufalin. Read the full article: Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelance…

Podcasts Worth a Listen

Parp Inhibitors Podcasts

Podcasts Worth a Listen

Quick Reference Guide